| Literature DB >> 28237252 |
Alexandre Delamou1, Alison M El Ayadi2, Sidikiba Sidibe3, Therese Delvaux4, Bienvenu S Camara5, Sah D Sandouno6, Abdoul H Beavogui5, Georges W Rutherford7, Junko Okumura8, Wei-Hong Zhang9, Vincent De Brouwere4.
Abstract
BACKGROUND: The 2014 west African epidemic of Ebola virus disease posed a major threat to the health systems of the countries affected. We sought to quantify the consequences of Ebola virus disease on maternal and child health services in the highly-affected Forest region of Guinea.Entities:
Mesh:
Year: 2017 PMID: 28237252 PMCID: PMC6530984 DOI: 10.1016/S2214-109X(17)30078-5
Source DB: PubMed Journal: Lancet Glob Health ISSN: 2214-109X Impact factor: 26.763
Figure 1:Health districts in the Forest region, Guinea, included in the study
Demographic characteristics of the study population by health district
| Total population in 2014 | Children aged <12 months | Antenatal care target (number of women) | Ebola virus disease cases | Ebola virus disease incidence | |
|---|---|---|---|---|---|
| Beyla | 326 082 | 13 043 | 14 674 | 47 | 1.4 |
| Gueckédou | 290 611 | 11 624 | 13 077 | 382 | 13.1 |
| Kissidougou | 283 778 | 11 351 | 12 770 | 136 | 4.8 |
| Lola | 171561 | 6 862 | 7720 | 111 | 6.5 |
| Macenta | 278 456 | 11 138 | 12 531 | 744 | 26.7 |
| N’zerekore | 396 949 | 15 878 | 17 863 | 256 | 6.4 |
| Total | 1747 437 | 69 897 | 78 635 | 1676 | 9.6 |
Per 10 000 person-years during March, 2014–February, 2015.
Figure 2:Number of women receiving at least one or at least three antenatal care visits and number giving birth in a health facility, Forest region, Guinea from January, 2013, to February, 2016
EVD=Ebola virus disease.
Parameter estimates for monthly maternal indicators in the Forest region, Guinea, from January, 2013, to February, 2016
| At least one antenatal care visit | Three or more antenatal care visits | Institutional deliveries | |||||||
|---|---|---|---|---|---|---|---|---|---|
| β | 95% CI | p value | β | 95% CI | p value | β | 95% CI | p value | |
| Number of women using service at beginning of pre-Ebola Period (β0) | 9568 | 8941 to 10 195 | <0.0001 | 7555 | 7098 to 8012 | <0.0001 | 3602 | 3345 to 3859 | <0.0001 |
| Average monthly change in number using service over pre-Ebola period (β1) | 109 | 54 to 164 | 0.0005 | 119 | 79 to 158 | <0.0001 | 61 | 38 to 84 | <0.0001 |
| Average monthly change in number using service during Ebola virus disease outbreak (β2) | −923 | −1882 to 36 | 0.0585 | −624 | −1568 to 320 | 0^1834 | 72 | −333 to 476 | 0.7163 |
| Difference between trend in service use during Ebola virus disease outbreak compared with pre-disease period (β3) | −418 | −535 to −300 | <0.0001 | −363 | −485 to −242 | <0.0001 | −240 | −293 to −187 | <0.0001 |
| Average monthly change in number using service during post-Ebola period (β4) | 1712 | 357 to 3066 | 0.0157 | 103 | −1385 to 1590 | 0.8871 | 982 | 362 to 1602 | 0.0034 |
| Difference between trend in service use during post-Ebola period compared with outbreak period (β5) | 173 | 51 to 294 | 0.0074 | 257 | 117 to 398 | 0.0010 | 149 | 91 to 206 | <0.0001 |
| Overall trends | |||||||||
| Linear trend during outbreak (β1 + β3) | −309 | −428 to −189 | <0.0001 | −244 | −369 to −119 | 0.0006 | −179 | −233 to −125 | <0.0001 |
| Linear trend after outbreak (β1 + β3 plus β5) | −136 | −231 to −40 | 0.0075 | 13 | −109 to 134 | 0.8286 | −30 | −80 to 20 | 0.2294 |
Data are from the segmented ordinary least–square regression model adjusted for birth seasonality. p value tests the null hypothesis that each of the coefficients is equal to zero, following the model specification and description in the methods section.
Parameter estimates for monthly childhood vaccinations in the Forest region, Guinea, from January, 2013, to February, 2016
| BCG | Pentavalent | Polio | Measles | Yello wfever | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| β | 95% Cl | p val ue | β | 95% Cl | p value | β | 95% Cl | p value | β | 95% Cl | p value | β | 95% Cl | p value | |
| Number of childhood vaccinations at beginning of pre-Ebola period (β0) | 5752 | 2821 to 8682 | 0.0005 | 7498 | 7154 to 7841 | <0.0001 | 6953 | 6380 to 7526 | <0.0001 | 7788 | 7443 to 8133 | <0.0001 | 8043 | 7621 to 8464 | <0.0001 |
| Average monthly change in number of vaccinations over pre-Ebola period (β1) | 321 | 58 to 584 | 0.0193 | 93 | 50 to 136 | 0.0002 | 118 | 47 to 190 | 0.0025 | 119 | 53 to 185 | 0.0012 | 106 | 44to 167 | 0.0017 |
| Average monthly change in number of vaccinations during Ebola virus disease outbreak (β2) | −3048 | −5879 to-216 | 0.0362 | −1483 | −2469 to-497 | 0.0051 | −3594 | −4811 to-2377 | <0.0001 | −1328 | −2474to-l82 | 0.0252 | −1075 | −215 8 to 7 | 0.0514 |
| Difference between trend in vaccinations during Ebola virus disease outbreak compared with p re-disease period (β3) | −419 | −683 to-155 | 0.0034 | −313 | −446 to-179 | <0.0001 | −108 | −276 to 61 | 01976 | −357 | −483 to-231 | <0.0001 | −363 | −488 to-238 | <0.0001 |
| Average monthly change in number of vacc i nati on s d u ri ng post-Ebola period (β4) | 128 | −2776 to 3031 | 0.928 | 655 | −1009 to 2320 | 0422 | 76 | −1145 to 1297 | 0.898 | 1024 | −516 to 2565 | 0481 | 1295 | −245 to 2835 | 0.095 |
| Difference between trend in vaccinations during post-Ebola period compared with outbreak period (β5) | −127 | −328 to 73 | 0.2014 | 154 | 10 to 299 | 0.0373 | −107 | −262 to 47 | 01630 | 81 | −27 to 189 | 0.1338 | 58 | −57 to 172 | 0.3056 |
| Overall trends | |||||||||||||||
| Lineartrend during outbreak (β1 + β3) | −99 | −332 to 135 | 0.3899 | −220 | −3 63 to-77 | 0.0042 | 11 | −139 to 161 | 0.8841 | −238 | −371 to-105 | 0.0013 | −258 | −391 to-125 | 0.0006 |
| Lineartrend after outbreak (β1 + β3 + β5) | −226 | −520 to 68 | 0.1251 | −66 | −201 to 70 | 0.3248 | −97 | −179 to-14 | 0.0240 | −157 | −249 to-65 | 0.0018 | −200 | −298 to-102 | 0.0004 |
Data are from the segmented ordinary least–square regression model. BCG=Bacille Calmette-Guerin (anti-tuberculosis vaccine). p value tests the null hypothesis that each of the coefficients is equal to zero, following the model specification and description in the methods section.
Figure 3:Number of children younger than 12 months covered by vaccines, in the Forest region, Guinea from January, 2013, to February, 2016
Vaccines analysed were BCG (anti-tuberculosis vaccine), pentavalent(a combination of five vaccines in one: diphtheria, tetanus, pertussis, hepatitis B virus, and Haemophilus influenzae type b), poliovaccine, Rouvax (anti-measles vaccine), and anti-amaril [yellow fever] vaccine). EVD=Ebola virus disease.